Carregant...
Fitxers
Tipus de document
ArticleVersió
Versió publicadaData de publicació
Llicència de publicació
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/225386
COVID-19 in Relation to Polypharmacy and Immunization (2020-2024)
Títol de la revista
Director/Tutor
ISSN de la revista
Títol del volum
Recurs relacionat
Resum
Background: Observational studies reported worse COVID-19 evolution in relation to polypharmacy and reductions in COVID-19 hospital admissions and death in patients receiving chronic antihistamine treatment. The current profile of hospitalized patients with regard to different variants was analyzed to identify specific targets for future prospective trials. Methods: COVID-19 admissions to the Hospital of Terrassa (11 March 2020–28 August 2024 (n = 1457), from the integral Consorci Sanitari de Terrassa population (n = 167,386 people) were studied. Age, gender, the number of chronic treatments (nT), and immunization status were analyzed. Results: After 5 May 2023, 291 patients (54% females) required COVID hospitalization. Of these, 39% received >8 nT (23% receiving 5–7 nT), 70.2% were >70 years, and 93.4% survived. In total, 12% of patients admitted after 5 May 2024 were not vaccinated, while 59% received ≥4 vaccines (43% within the last 12 months). In total, 49% of admitted patients presented no previous infection (while 3% presented infection during the last year). Delta or Omicron variants would have accounted for ≥80% of admissions > 60 years compared to the first pandemic wave if no vaccines existed. Conclusions: Patients > 70 years who receive ≥5 nT, without prior COVID-19 infections, should be the priority for prevention, with updated vaccination and early treatments to reduce hospitalizations.
Matèries (anglès)
Citació
Citació
PUIGDELLÍVOL SÁNCHEZ, Anna, JUANES GONZÁLEZ, Marta, CALDERÓN VALDIVIEZO, Ana, VALLS FOIX, Roger, GONZÁLEZ SALVADOR, Marta, LOZANO PAZ, Celia, VIDAL ALABALL, Josep. COVID-19 in Relation to Polypharmacy and Immunization (2020-2024). _Viruses_. 2024. Vol. 16, núm. 10. [consulta: 27 de gener de 2026]. ISSN: 1999-4915. [Disponible a: https://hdl.handle.net/2445/225386]